NIDDK at 75 Years of Age: Great Triumphs but Concerns for Its Longevity.
作者信息
Kahn Steven E, Anderson Cheryl A M, Buse John B, Selvin Elizabeth, D'Alessio David A
机构信息
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA.
Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA.
出版信息
Diabetes. 2025 Jul 1;74(7):1050-1052. doi: 10.2337/dbi25-0019.
Abstract
摘要
相似文献
1
NIDDK at 75 Years of Age: Great Triumphs but Concerns for Its Longevity.
Diabetes. 2025 Jul 1;74(7):1050-1052. doi: 10.2337/dbi25-0019.
2
NIDDK at 75 Years of Age: Great Triumphs but Concerns for Its Longevity.
Diabetes Care. 2025 Jul 1;48(7):1083-1084. doi: 10.2337/dci25-0033.
3
Interventions for great saphenous vein incompetence.
Cochrane Database Syst Rev. 2021 Aug 11;8(8):CD005624. doi: 10.1002/14651858.CD005624.pub4.
4
Thermal biology of Hypogeococcus pungens (Hemiptera: Pseudococcidae) explains its variable performance as a classical biological control agent for Harrisia martinii (Cactaceae) in Australia.
Environ Entomol. 2025 Jun 18;54(3):454-466. doi: 10.1093/ee/nvaf026.
5
Interventions to prevent injuries in construction workers.
Cochrane Database Syst Rev. 2018 Feb 5;2(2):CD006251. doi: 10.1002/14651858.CD006251.pub4.
6
Reminiscence therapy for dementia.
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
7
Heliox for croup in children.
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD006822. doi: 10.1002/14651858.CD006822.pub6.
8
Maternal and neonatal outcomes of elective induction of labor.
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
9
Prophylactic drug management for febrile seizures in children.
Cochrane Database Syst Rev. 2017 Feb 22;2(2):CD003031. doi: 10.1002/14651858.CD003031.pub3.
10
Colchicine for acute gout.
Cochrane Database Syst Rev. 2021 Aug 26;8(8):CD006190. doi: 10.1002/14651858.CD006190.pub3.
本文引用的文献
1
Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding.
Diabetes Care. 2025 Jul 1;48(7):1112-1124. doi: 10.2337/dc24-2908.
2
Youth-Onset Type 2 Diabetes: What We've Learned From Key Youth-Onset Type 2 Diabetes Studies, What We Still Don't Know, and Why It Is Important.
Diabetes Care. 2025 Jul 1;48(7):1136-1149. doi: 10.2337/dc25-0001.
3
The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact.
Diabetes Care. 2025 Jul 1;48(7):1101-1111. doi: 10.2337/dc25-0014.
4
Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study.
Diabetes Care. 2025 Jul 1;48(7):1125-1135. doi: 10.2337/dc24-2886.
5
The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Diabetes Care. 2025 Jul 1;48(7):1089-1100. doi: 10.2337/dc24-2885.
6
Advances in Cell Replacement Therapies for Diabetes.
Diabetes. 2025 Apr 24. doi: 10.2337/db25-0037.
7
Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.
Diabetes. 2025 Jul 1;74(7):1057-1067. doi: 10.2337/db25-0097.
8
9
Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data.
Diabetes. 2025 Jul 1;74(7):1089-1098. doi: 10.2337/db25-0042.
10
Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic Diseases.
Diabetes. 2025 Jul 1;74(7):1099-1106. doi: 10.2337/db25-0039.
Zotero 插件